Official websites use .gov
A
.gov website belongs to an official government
organization in the United States.
Secure .gov websites use HTTPS
A
lock (
) or https:// means you’ve safely connected to
the .gov website. Share sensitive information only on official,
secure websites.
This fact sheet discusses how mpox can spread to anyone through close (often skin-to-skin) contact. This includes intimate contact (kissing, touching, any kind of sex). If your partner has mpox, avoid sex or being intimate until all sores have healed and a fresh layer of skin has formed.
This fact sheet discusses how mpox is a rare but potentially serious disease that is caused by the mpox virus. The mpox virus is from the same family of viruses as the smallpox virus. The symptoms of mpox are similar to smallpox symptoms, but are less severe. It is also less transmissible than smallpox, and rarely fatal. The mpox virus can spread from infected humans, animals, and materials contaminated with the virus. The mpox virus is characterized by a new unexplained rash and skin lesions.
One of four pre-recorded video presentations on the current landscape of U.S. government-supported mpox research. The highlighted research efforts include Phase III clinical trials of tecovirimat (TPOXX) to treat mpox.
Contact organization for eligibility
A video summary on mpox research and development in the field of diagnostics conducted by the U.S. government.
A video summary of current scientific studies conducted by U.S. government agencies on mpox vaccine effectiveness, safety, equity, and development.
A video summary of current scientific studies conducted by U.S. government agencies on mpox surveillance and population science.
This webpage discusses how mpox (formerly known as monkeypox) is caused by a virus that is related to the virus that causes smallpox. JYNNEOS is a two-dose vaccine developed to protect against mpox and smallpox infections. People need to get both doses of the vaccine for the best protection against mpox. The second dose should be given four weeks after the first dose.
This infographic discusses how in 2018, injection drug use (IDU) was highest among men (21%),
This video discusses an overview of the new GHSS, the five strategic directions, and the 2025 and 2030 targets.
The progress countries have made to these goals and what needs to be done to achieve them.
How community-based organizations and activists can use the GHSS and its targets for advocacy and to hold countries and health systems accountable to their commitments.
Good practice examples of using the previous GHSS for advocacy and how countries have used GHSS in the planning and implementation of their national programmes.
